5-HT2A/2C receptors are one of the most important in controlling basal ganglia outputs. In rodent models of Parkinson's disease (PD) blockade of these receptors increases locomotion and enhances the actions of dopamine (DA) replacement therapy. Moreover, previously we established that 5-HT 2A/2C antagonist attenuate DA D1 agonist mediated vacuous chewing movements (VCMs) which are considered as an animal representation of human dyskinesia. These findings implicate 5-HT neuronal phenotypes in basal ganglia pathology, and promote 5-HT2 antagonists as a rational treatment approach for dyskinesia that is prominent in most instances of PD replacement therapy. In the current study we determined whether ketanserin (KET) and/or amphetamine (AMPH) affected dopaminergic neurotranssmision in intact and fully DA-denervated rats. Moreover, we looked into extraneuronal content of HO. of the neostriatum after AMPH and/or KET injection, assessed by HPLC analysis of dihydroxybenzoic acids (2,3- and 2, 5-DHBA) - spin trap products of salicylate. Findings from the present study demonstrated that there are no substantial differences in extraneuronal HO. generation in the neostriatum between control and parkinsonian rats. KET did not affect DA release in the fully DA-denervated rat's neostriatum and also did not enhance HO. production. As 5-HT2A/2C receptor-mediated transmission might prove usefulness not only in addressing motor complications of PD patients (dyskinesia) but also in addressing non-motor problems such depression and/or L-DOPA evoked psychosis, the findings from the current study showed that the use of 5-HT2A/2C receptor antagonists in Parkinson's disease does not impend the neostriatal neuropil to be damaged by these drugs. We concluded that 5-HT2A/2C receptor antagonists may provide an attractive non-dopaminergic target for improving therapies for some basal ganglia disorders.

In agreement with previous work, adult rats given selective lesions to dopamine (DA)-containing neurons as neonates exhibited a greater behavioral sensitization to repeated phencyclidine (PCP) treatment in comparison to sham-lesioned controls. Acute administration of olanzapine (1-5 mg/kg ip) or clozapine (15 mg/kg ip) decreased sensitized PCP-induced activity in both lesioned and control animals. Acute haloperidol (0.5 mg/kg ip) had no impact on PCP responsiveness in lesioned animals, but significantly antagonized PCP effects in sham-lesioned controls. Ketanserin, a selective 5-HT 2A/5-HT2C-receptor antagonist, significantly reduced PCP activation in both lesioned and control rats, suggesting that the efficacy of atypical antipsychotics against PCP-induced sensitized responses may be mediated by one of the 5-HT2-receptor subtypes. A 6-week chronic regimen of orally administered olanzapine, clozapine, or haloperidol failed to block the sensitization induced by repeated PCP exposure. However, a 10-month oral olanzapine treatment significantly blunted the behavioral sensitization to repeated PCP exposure in lesioned animals, even after withdrawal from chronic olanzapine for more than 3 weeks. A 10-month oral haloperidol treatment had no effect on the sensitization induced by repeated PCP dosing. The persistent effect of chronic olanzapine administration on PCP sensitization may be relevant to the chronic therapeutic efficacy of atypical antipsychotics treating schizophrenia - a clinical syndrome linked to enhanced sensitivity to N-methyl-D-aspartate (NMDA)-receptor antagonists.

Schizophrenia is a chronic psychotic illness affecting ~21 million people globally. Currently available antipsychotic agents act through a dopamine D2 receptor mechanism, and produce extrapyramidal or metabolic side effects. Hence, there is a need for novel targets and agents. The mGlu2/5-HT2A receptor heteromer has been implicated in the action of antipsychotic agents, and represents a novel and attractive therapeutic target for the treatment of schizophrenia. A long-term goal of this project is to synthesize bivalent ligands where a 5-HT2A receptor antagonist is tethered to an mGlu2 PAM via a linker. The goals of the investigation were to study the SAR of risperidone (an atypical antipsychotic agent) at 5-HT2A receptors using a “deconstruction-reconstruction-elaboration” approach to determine the minimal structural features of risperidone that contribute to its 5-HT2A receptor affinity and antagonism, and to determine where on the “minimized risperidone” structure an mGlu2 PAM can be introduced. Additional goals included studying the binding modes of various mGlu2 PAMs and identifying where on an mGlu2 PAM a risperidone “partial” structure could be introduced. Biological studies of deconstructed/elaborated analogs of risperidone suggest that the entire structure of risperidone is not necessary for 5-HT2A receptor affinity and antagonism, and that a fluoro group contributes to 5-HT2A binding. 6-Fluoro-3-(4-piperidinyl)-1,2-benz[d]isoxazole that has only half the structural features of risperidone retains 5-HT2A receptor affinity and antagonist activity, and represents the “minimized risperidone” structure with the piperidine nitrogen atom representing a potential linker site for eventual construction of bivalent ligands. Molecular modeling studies at 5-HT2A receptors suggest that risperidone and its analogs have more than one binding mode. Modeling studies to evaluate binding modes of various PAMs at mGlu2 receptors, coupled with known SAR information, were used to identify a PAM (JNJ-40411813), and the pyridone nitrogen atom of JNJ-40411813 as a potential linker site. Additionally, potential synthetic routes for JNJ-40411813 were explored that might be of value in the synthesis of bivalent ligands. Based on the structural features of 6-fluoro-3-(4-piperidinyl)-1,2-benz[d]isoxazole, a new pharmacophore for 5-HT2A receptor antagonists, consisting of one aromatic region, a basic protonated amine and hydrogen bond acceptors, has been proposed.

Sabe-se que o medo condicionado contextual (MCC) pode ativar diversas áreas mesencefálicas, como a Substância Cinzenta Periaquedutal Dorsal (SCPd). Diversos estudos avaliaram como mecanismos serotoninérgicos modulam o comportamento defensivo induzido pela estimulação elétrica da SCPd. Uma função proeminente dos receptores 5-HT2A é regular estados aversivos induzidos pela ativação da SCPd e, apesar de saber que experiências aversivas prévias exercem um importante papel em determinados tipos de ansiedade, somente estudos com estimulação da SCPd de ratos sem experiência aversiva prévia foram conduzidos até o momento. O objetivo do presente estudo foi investigar o papel funcional dos receptores 5-HT2A localizados nos substratos neurais da aversão na SCPd de ratos previamente submetidos ao condicionamento contextual aversivo. Foram avaliadas as respostas de congelamento e fuga obtidas a partir do procedimento de estimulação elétrica da SCPd na sessão teste, realizada 24 horas após o condicionamento, quando os animais foram recolocados no contexto previamente pareado com choques nas patas ou no contexto diferente. A função dos receptores 5-HT2A da SCPd foi avaliada pela injeção local de -metil-serotonina ou cetanserina, agonista e antagonista seletivos de receptores do tipo 5-HT2A, respectivamente. De acordo com estudos anteriores, a -metil-serotonina aumentou os limiares aversivos (efeito antiaversivo) determinados pela estimulação da SCPd em animais ingênuos, enquanto que a injeção de cetanserina não produziu qualquer efeito significativo. No presente estudo, a cetanserina reduziu o limiar de congelamento (efeito proaversivo), enquanto que a -metil-serotonina continuou apresentando efeito antiaversivo em animais com experiência aversiva prévia (choques nas patas). Estes resultados sugerem que experiências aversivas anteriores podem produzir importantes alterações na função sináptica dos receptores 5-HT2A da SCPd, podendo refletir na reatividade da SCPd à sua estimulação aversiva. / It has been shown that contextual fear conditioning (CFC) may activate brainstem regions such as the dorsal periaqueductal gray (dPAG). Several studies have been carried out to disclose how 5-HT2 mechanisms modulate the aversive stimulation of the dPAG. One prominent function of 5-HT2 receptors is to regulate the aversive states induced by activation of the dPAG. However, in spite of the notion that past stressful experiences play a crucial role in certain types of anxiety only studies with stimulation of the dPAG of rats without previous aversive experience have been conducted so far. We investigated the mediation of 5-HT2 receptors located in the neural substrates of aversion of the dPAG in rats previously submitted to CFC. Defensive behaviors induced by activation of the dPAG were assessed by measuring the lowest intensity of electric current applied to this structure (threshold) able to produce freezing and escape responses during testing sessions of CFC, in which animals were placed in a context previously paired to footshocks. The 5-HT2 function of the dPAG in this condition was evaluated by local injections of -methyl-5-HT and ketanserin, selective agonist and antagonist of 5-HT2 receptors, respectively. In accordance with previous studies, -methyl-5-HT increased the aversive thresholds (antiaversive effects) determined by stimulation of the dPAG in naive rats and injection of ketanserin into the dPAG did not produce any significant effects. On the other hand, ketanserin decreased the freezing threshold (proaversive effect) determined by the dPAG electrical stimulation while -methyl-5-HT continued to show antiaversive effects in animals with prior experience with foot shocks. The present results suggest that a past stressful experience can produce changes in the synaptic function of 5-HT2 receptors within the dPAG with important impact on the defensive behaviors induced by electrical stimulation of this area.

Sabe-se que o medo condicionado contextual (MCC) pode ativar diversas áreas mesencefálicas, como a Substância Cinzenta Periaquedutal Dorsal (SCPd). Diversos estudos avaliaram como mecanismos serotoninérgicos modulam o comportamento defensivo induzido pela estimulação elétrica da SCPd. Uma função proeminente dos receptores 5-HT2A é regular estados aversivos induzidos pela ativação da SCPd e, apesar de saber que experiências aversivas prévias exercem um importante papel em determinados tipos de ansiedade, somente estudos com estimulação da SCPd de ratos sem experiência aversiva prévia foram conduzidos até o momento. O objetivo do presente estudo foi investigar o papel funcional dos receptores 5-HT2A localizados nos substratos neurais da aversão na SCPd de ratos previamente submetidos ao condicionamento contextual aversivo. Foram avaliadas as respostas de congelamento e fuga obtidas a partir do procedimento de estimulação elétrica da SCPd na sessão teste, realizada 24 horas após o condicionamento, quando os animais foram recolocados no contexto previamente pareado com choques nas patas ou no contexto diferente. A função dos receptores 5-HT2A da SCPd foi avaliada pela injeção local de -metil-serotonina ou cetanserina, agonista e antagonista seletivos de receptores do tipo 5-HT2A, respectivamente. De acordo com estudos anteriores, a -metil-serotonina aumentou os limiares aversivos (efeito antiaversivo) determinados pela estimulação da SCPd em animais ingênuos, enquanto que a injeção de cetanserina não produziu qualquer efeito significativo. No presente estudo, a cetanserina reduziu o limiar de congelamento (efeito proaversivo), enquanto que a -metil-serotonina continuou apresentando efeito antiaversivo em animais com experiência aversiva prévia (choques nas patas). Estes resultados sugerem que experiências aversivas anteriores podem produzir importantes alterações na função sináptica dos receptores 5-HT2A da SCPd, podendo refletir na reatividade da SCPd à sua estimulação aversiva. / It has been shown that contextual fear conditioning (CFC) may activate brainstem regions such as the dorsal periaqueductal gray (dPAG). Several studies have been carried out to disclose how 5-HT2 mechanisms modulate the aversive stimulation of the dPAG. One prominent function of 5-HT2 receptors is to regulate the aversive states induced by activation of the dPAG. However, in spite of the notion that past stressful experiences play a crucial role in certain types of anxiety only studies with stimulation of the dPAG of rats without previous aversive experience have been conducted so far. We investigated the mediation of 5-HT2 receptors located in the neural substrates of aversion of the dPAG in rats previously submitted to CFC. Defensive behaviors induced by activation of the dPAG were assessed by measuring the lowest intensity of electric current applied to this structure (threshold) able to produce freezing and escape responses during testing sessions of CFC, in which animals were placed in a context previously paired to footshocks. The 5-HT2 function of the dPAG in this condition was evaluated by local injections of -methyl-5-HT and ketanserin, selective agonist and antagonist of 5-HT2 receptors, respectively. In accordance with previous studies, -methyl-5-HT increased the aversive thresholds (antiaversive effects) determined by stimulation of the dPAG in naive rats and injection of ketanserin into the dPAG did not produce any significant effects. On the other hand, ketanserin decreased the freezing threshold (proaversive effect) determined by the dPAG electrical stimulation while -methyl-5-HT continued to show antiaversive effects in animals with prior experience with foot shocks. The present results suggest that a past stressful experience can produce changes in the synaptic function of 5-HT2 receptors within the dPAG with important impact on the defensive behaviors induced by electrical stimulation of this area.